Endocrine disruptor assessment list

Endocrine disruptor assessment list

Endocrine disruptor assessment list

ECHA’s endocrine disruptor (ED) assessment list includes the substances undergoing an ED assessment that have been brought for discussion to ECHA’s ED Expert Group.

Explanatory note

Inclusion in the list means that an informal hazard assessment for endocrine-disrupting properties either is under development or has been completed since February 2013.

For each substance, the table shows the assessing or evaluating Member State (submitter), the outcome from the assessment, and the date of the latest update to the list entry.

Other process details and hazard assessment outcome documents are also available and can be accessed through the ‘Details’ icon.

One possible outcome of such an assessment is that a substance is considered not to have ED properties.

If the outcome is that the substance is considered to have ED properties, confirmation through the formal risk management and decision-making processes under is needed before any regulatory action can be taken due to these properties.

The intentions of authorities to submit a dossier to the formal REACH and CLP processes are notified through the Registry of Intentions. All biocidal active substances have to undergo a formal ED assessment. You can see the status of biocides assessments on the Biocidal Active Substances page.


The information and views set out in the ED assessment list and in the hazard assessment outcome documents are those of the evaluating authority and do not necessarily reflect the position or opinion of the other Member States or ECHA. Neither ECHA nor the evaluating authority nor any person acting on either of their behalves may be held liable for the use, which may be made of the information contained therein. Statements made or information contained in the documents are without prejudice to any formal regulatory activities that ECHA or the Member States may initiate at a later stage. ED assessments and their outcomes are compiled on the basis of information available by the date of the publication of the document.


EC / List no: 201-289-8 CAS no: 80-54-6
Endocrine disruption
Date of intention
Date of hazard assessment
Hazard assessment outcome document
According to the substance evaluation conclusion document the ED HH and ED ENV concerns could not be resolved.

For ED HH, the EOGRTS was requested to also address the potential ED properties of the Substance. The study did not confirm ED properties. However, as the EOGRTS was performed at low doses no definitive conclusion could be reached.

For ED ENV a Fish short-term reproductive toxicity screening study (FSTRA) was requested under SEv to address the potential ED properties in the environment. The results were inconclusive.
Submitter organisation
Swedish Chemicals Agency
Submitter email
Submitter phone
+ 46 8 519 41 100
Submitter address
Latest update
First published